Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-20Clinical Trial Results: Management of Cardiovascular Disease in Kidney Disease (MaCK) Study [Phase 2]
Phase 2 clinical trial results for MaCK study addressing management of cardiovascular disease in patients with chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2026-08-14Clinical Trial Results: Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression [Phase 4]
Phase 4 trial assessing DNA testing to guide transition of kidney transplant recipients to belatacept-only immunosuppression.
-
CLINICAL_TRIALS trial_result · 2026-08-11Clinical Trial Results: A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP [Phase 2]
Phase 2 clinical trial results for TOUR006 in patients with chronic kidney disease and elevated hs-CRP have been completed with results post…
-
CLINICAL_TRIALS trial_result · 2026-08-11Clinical Trial Results: Multicultural Healthy Diet in Chronic Kidney Disease [NA]
Completed clinical trial evaluating a multicultural healthy diet in chronic kidney disease; results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-28Clinical Trial Update: ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation [Phase 3]
Phase 3 trial update for ZEUS evaluating ziltivekimab versus placebo in individuals with cardiovascular risk, chronic kidney disease, and in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-07-28Clinical Trial Results: Bone in CKD Alkali Response (BICARb Pilot Trial) [Phase 2, Phase 3]
Phase 2/3 trial in CKD-related bone loss was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-27Clinical Trial Results: Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients [Phase 4]
Phase 4 clinical trial investigating pioglitazone to reduce sympathetic overactivity in chronic kidney disease patients.
-
CLINICAL_TRIALS trial_result · 2026-07-13Clinical Trial Results: A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes [Phase 2]
Phase 2 trial evaluating finerenone with empagliflozin versus each monotherapy in adults with type 2 diabetes and chronic kidney disease; re…
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis [Phase 3]
Phase 3 trial evaluating safety and efficacy of Hectorol in pediatric CKD stage 3-4 with secondary hyperparathyroidism; study terminated wit…
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Update: ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE [Phase 3]
Phase 3 trial update for Ravulizumab (ARTEMIS) evaluating protection against CSA-AKI and MAKE in chronic kidney disease patients.
-
CLINICAL_TRIALS trial_result · 2026-06-26Clinical Trial Results: Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease [Phase 2]
Phase 2 trial comparing Balcinrenone/Dapagliflozin versus Dapagliflozin in adults with chronic kidney disease; results posted and study comp…
-
CLINICAL_TRIALS trial_result · 2026-06-23Clinical Trial Results: JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD)
Post-marketing surveillance study results for JARDIANCE in Korean patients with chronic kidney disease have been completed and results poste…
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Update: ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE [Phase 3]
Phase 3 trial update for ravulizumab (ARTEMIS) in CKD patients to protect against CSA-AKI and MAKE events; study completed.
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Results: A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD) [Phase 3]
Phase 3 study evaluating safety, efficacy, and pharmacokinetics of paricalcitol for pediatric secondary hyperparathyroidism in stage 5 chron…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Results: Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria [Phase 2]
Phase 2 trial results evaluate lorundrostat added to SGLT2 inhibitors in patients with hypertension and chronic kidney disease with albuminu…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial investigates effervescent calcium-magnesium citrate as a potential therapy for chronic kidney disease stage…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease [Phase 3]
Phase 3 clinical trial evaluating roxadustat to treat anemia in children and adolescents with chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Lokelma for RAAS Maximisation in CKD & Heart Failure. [Phase 3]
Phase 3 trial update for Lokelma evaluating potassium management to maximize RAAS inhibition in chronic kidney disease and heart failure wit…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Lokelma for RAAS Maximisation in CKD & Heart Failure. [Phase 3]
Phase 3 trial update for Lokelma aimed at maximizing RAAS inhibition in CKD and heart failure with reduced ejection fraction; study complete…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function [Phase 3]
Phase 3 trial evaluating Balcinrenone and Dapagliflozin in patients with heart failure and impaired kidney function is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease [Phase 4]
A Phase 4 clinical trial is evaluating the efficacy and safety of SGLT2 inhibitors in adolescents with early-stage chronic kidney disease an…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease. [Phase 2]
Phase 2 trial investigating the mechanistic effects of dapagliflozin alone or with Balcinrenone on body fluid/electrolyte handling and energ…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease [Phase 2]
Phase 2 trial investigating a JAK-STAT pathway inhibitor for APOL1-associated kidney disease has completed (sponsor: Duke University).
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment [Phase 1]
Phase 1 study evaluating the pharmacokinetics and safety of LY3537031 in healthy participants and those with renal impairment has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD
A completed Duke University trial reported results on improving screening and therapy for Hispanic/Latinx individuals at risk for chronic ki…